Moreover, we unearthed that the DUSP5 was upregulated in various cancers, including invasive breast carcinoma, cholangiocarcinoma, thyroid carcinoma, and esophageal carcinoma (Figure S4A). Here, DUSP5 is linked to thyroid gland carcinoma.